A. Evidence from observational studies and reviews indicates that resuming anticoagulation after intracerebral hemorrhage is feasible in appropriately selected patients and does not significantly raise the risk of recurrent ICH while lowering thrombo-embolic events [Goldstein & Greenberg, 2010, PMID 21048052; Li & Lip, 2018, PMID 29781063].